SAN FRANCISCO, June 16, 2025--(BUSINESS WIRE)--64x Bio, a biotech company developing scalable solutions for the production of advanced therapies, today announced the launch of AAV Apex Suite, a high ...
Five global biopharma and CDMO leaders have entered strategic collaborations for AAV Apex Suite. High performance product line built on 64x Bio’s VectorSelect platform, delivering titers exceeding E15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results